The biggest UK trial for secondary progressive MS, conducted by Professor Jeremy Chataway (UCL Queen Square Institute of Neurology), is looking at whether simvastatin, a drug used to treat high cholesterol, can slow or stop the progression of MS.
Read: BBC News
Close
